Comparison · NCT06291831-6345845e
Treated With Paxlovid vs Not Treated With Paxlovid: Number of Participants With Hospitalization for Any Cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Treated With Paxlovid vs Not Treated With Paxlovid: Number of Participants With Hospitalization for Any Cause. Trial comparisons, record NCT06291831-6345845e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT06291831-6345845e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0683 | 0.0581 | 0.0802 | wilson | |
| Risk in group 2 | 0.122 | 0.103 | 0.144 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0539 | -0.0779 | -0.0317 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.559 | 0.443 | 0.704 | log | |
| Odds ratio, group 1 over group 2 | 0.527 | 0.407 | 0.68 | log | |
| Number needed to treat, for one fewer participant with the outcome on Treated With Paxlovid than on Not Treated With Paxlovid | 18.5 | 12.8 | 31.6 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Treated With Paxlovid | Participants who were diagnosed with COVID-19 and accepted offer for treatment with Paxlovid (nirmatrelvir, ritonavir) treatment in real world setting. No intervention was administered under this study. | 137 | 2,005 | OG000 |
| Group 2 | Not Treated With Paxlovid | Participants who were diagnosed with COVID-19 and declined offer for treatment with Paxlovid (nirmatrelvir, ritonavir) treatment. This reporting arm served as control group. | 123 | 1,006 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Hospitalization for Any Cause
- Description
- Time frame
- Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study
- Population
- Analysis population included all eligible participants whose data were included and observed in this study.
Source ClinicalTrials.gov
Trial
- Title
- A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.
- NCT number
- NCT06291831
- Phases
- Conditions
- COVID-19
- Interventions
- nirmatrelvir, ritonavir, Controls
- Lead sponsor
- Pfizer
- Results first posted
- 2025-08-19
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT06291831?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT06291831-6345845e